Skip to main content
Top
Published in: BMC Nephrology 1/2014

Open Access 01-12-2014 | Research article

Primary care physicians’ familiarity, beliefs, and perceived barriers to practice guidelines in non-diabetic CKD: a survey study

Authors: Khaled Abdel-Kader, Raquel C Greer, L Ebony Boulware, Mark L Unruh

Published in: BMC Nephrology | Issue 1/2014

Login to get access

Abstract

Background

Most non-dialysis dependent chronic kidney disease (CKD) patients are cared for by their primary care physicians (PCPs). Studies suggest many CKD patients receive suboptimal care. Recently, CKD clinical practice guidelines were updated with additional emphasis on albuminuria.

Methods

We performed an internet-based, cross-sectional survey of active PCPs in the United States using the American Medical Association Physician Masterfile. We explored CKD guideline familiarity, self-reported practice behaviors, and attitudinal and external barriers to implementing guideline recommendations, including albuminuria testing.

Results

Of 12,034 PCPs targeted, 848 opened a study email, 165 (19.5%) responded. Most respondents (88%) spent ≥50% of their time in clinical care. Respondents were generally in private practice (46%). Most PCPs (96%) felt that eGFR values were helpful. Approximately, 75% and 91% of PCPs reported testing for albuminuria in non-diabetic hypertensive patients with an eGFR > 60 ml/min/1.73 m2 and < 60 ml/min/1.73 m2, respectively. Barriers to albuminuria testing included a lack of effect on management, limited time, and the perceived absence of guidelines recommending testing. While PCPs expressed high levels of agreement with the definition of CKD, 30% were concerned with overdiagnosis in older adults with an eGFR in the CKD stage 3a range. Most PCPs felt that angiotensin converting enzyme inhibitor (ACEi)/ angiotensin II receptor blockers (ARBs) improved outcomes in CKD, though agreement was lower with severe vs. moderate albuminuria (78% vs. 85%, respectively, p = 0.03). Many PCPs (51%) reported being unfamiliar with CKD guidelines, but were receptive to systematic interventions to improve their CKD care.

Conclusions

PCPs generally agree with CKD clinical practice guidelines regarding CKD definition and albuminuria testing. However, future interventions are necessary to improve PCPs’ familiarity with CKD guidelines, overcome barriers to albuminuria testing and, assist PCPs in targeting ACEi/ARBs to the patients most likely to benefit.
Appendix
Available only for authorised users
Literature
1.
go back to reference Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS: Prevalence of chronic kidney disease in the United States. JAMA. 2007, 298 (17): 2038-2047. 10.1001/jama.298.17.2038.CrossRefPubMed Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS: Prevalence of chronic kidney disease in the United States. JAMA. 2007, 298 (17): 2038-2047. 10.1001/jama.298.17.2038.CrossRefPubMed
2.
go back to reference Grams ME, Chow EK, Segev DL, Coresh J: Lifetime incidence of CKD stages 3–5 in the United States. Am J Kidney Dis. 2013, 62 (2): 245-252. 10.1053/j.ajkd.2013.03.009.CrossRefPubMedPubMedCentral Grams ME, Chow EK, Segev DL, Coresh J: Lifetime incidence of CKD stages 3–5 in the United States. Am J Kidney Dis. 2013, 62 (2): 245-252. 10.1053/j.ajkd.2013.03.009.CrossRefPubMedPubMedCentral
3.
go back to reference Shahinian VB, Saran R: The role of primary care in the management of the chronic kidney disease population. Adv Chronic Kidney Dis. 2010, 17 (3): 246-253. 10.1053/j.ackd.2010.02.003.CrossRefPubMed Shahinian VB, Saran R: The role of primary care in the management of the chronic kidney disease population. Adv Chronic Kidney Dis. 2010, 17 (3): 246-253. 10.1053/j.ackd.2010.02.003.CrossRefPubMed
4.
go back to reference Stevens LA, Fares G, Fleming J, Martin D, Murthy K, Qiu J, Stark PC, Uhlig K, Van Lente F, Levey AS: Low rates of testing and diagnostic codes usage in a commercial clinical laboratory: evidence for lack of physician awareness of chronic kidney disease. J Am Soc Nephrol. 2005, 16 (8): 2439-2448. 10.1681/ASN.2005020192.CrossRefPubMed Stevens LA, Fares G, Fleming J, Martin D, Murthy K, Qiu J, Stark PC, Uhlig K, Van Lente F, Levey AS: Low rates of testing and diagnostic codes usage in a commercial clinical laboratory: evidence for lack of physician awareness of chronic kidney disease. J Am Soc Nephrol. 2005, 16 (8): 2439-2448. 10.1681/ASN.2005020192.CrossRefPubMed
5.
go back to reference Minutolo R, De Nicola L, Mazzaglia G, Postorino M, Cricelli C, Mantovani LG, Conte G, Cianciaruso B: Detection and awareness of moderate to advanced CKD by primary care practitioners: a cross-sectional study from Italy. Am J Kidney Dis. 2008, 52 (3): 444-453. 10.1053/j.ajkd.2008.03.002.CrossRefPubMed Minutolo R, De Nicola L, Mazzaglia G, Postorino M, Cricelli C, Mantovani LG, Conte G, Cianciaruso B: Detection and awareness of moderate to advanced CKD by primary care practitioners: a cross-sectional study from Italy. Am J Kidney Dis. 2008, 52 (3): 444-453. 10.1053/j.ajkd.2008.03.002.CrossRefPubMed
6.
go back to reference Greer RC, Cooper LA, Crews DC, Powe NR, Boulware LE: Quality of patient-physician discussions about CKD in primary care: a cross-sectional study. Am J Kidney Dis. 2011, 57 (4): 583-591. 10.1053/j.ajkd.2010.08.027.CrossRefPubMed Greer RC, Cooper LA, Crews DC, Powe NR, Boulware LE: Quality of patient-physician discussions about CKD in primary care: a cross-sectional study. Am J Kidney Dis. 2011, 57 (4): 583-591. 10.1053/j.ajkd.2010.08.027.CrossRefPubMed
7.
go back to reference Allen AS, Forman JP, Orav EJ, Bates DW, Denker BM, Sequist TD: Primary care management of chronic kidney disease. J Gen Intern Med. 2011, 26 (4): 386-392. 10.1007/s11606-010-1523-6.CrossRefPubMed Allen AS, Forman JP, Orav EJ, Bates DW, Denker BM, Sequist TD: Primary care management of chronic kidney disease. J Gen Intern Med. 2011, 26 (4): 386-392. 10.1007/s11606-010-1523-6.CrossRefPubMed
8.
go back to reference Wyatt C, Konduri V, Eng J, Rohatgi R: Reporting of estimated GFR in the primary care clinic. Am J Kidney Dis. 2007, 49 (5): 634-641. 10.1053/j.ajkd.2007.02.258.CrossRefPubMed Wyatt C, Konduri V, Eng J, Rohatgi R: Reporting of estimated GFR in the primary care clinic. Am J Kidney Dis. 2007, 49 (5): 634-641. 10.1053/j.ajkd.2007.02.258.CrossRefPubMed
9.
go back to reference Plantinga LC, Miller ER, Stevens LA, Saran R, Messer K, Flowers N, Geiss L, Powe NR, Centers for Disease C: Blood pressure control among persons without and with chronic kidney disease: US trends and risk factors 1999–2006. Hypertension. 2009, 54 (1): 47-56. 10.1161/HYPERTENSIONAHA.109.129841.CrossRefPubMedPubMedCentral Plantinga LC, Miller ER, Stevens LA, Saran R, Messer K, Flowers N, Geiss L, Powe NR, Centers for Disease C: Blood pressure control among persons without and with chronic kidney disease: US trends and risk factors 1999–2006. Hypertension. 2009, 54 (1): 47-56. 10.1161/HYPERTENSIONAHA.109.129841.CrossRefPubMedPubMedCentral
10.
go back to reference Curtis BM, Barrett BJ, Djurdjev O, Singer J, Levin A: Evaluation and treatment of CKD patients before and at their first nephrologist encounter in Canada. Am J Kidney Dis. 2007, 50 (5): 733-742. 10.1053/j.ajkd.2007.08.004.CrossRefPubMed Curtis BM, Barrett BJ, Djurdjev O, Singer J, Levin A: Evaluation and treatment of CKD patients before and at their first nephrologist encounter in Canada. Am J Kidney Dis. 2007, 50 (5): 733-742. 10.1053/j.ajkd.2007.08.004.CrossRefPubMed
11.
go back to reference Philipneri MD, Rocca Rey LA, Schnitzler MA, Abbott KC, Brennan DC, Takemoto SK, Buchanan PM, Burroughs TE, Willoughby LM, Lentine KL: Delivery patterns of recommended chronic kidney disease care in clinical practice: administrative claims-based analysis and systematic literature review. Clin Exp Nephrol. 2008, 12 (1): 41-52. 10.1007/s10157-007-0016-3.CrossRefPubMed Philipneri MD, Rocca Rey LA, Schnitzler MA, Abbott KC, Brennan DC, Takemoto SK, Buchanan PM, Burroughs TE, Willoughby LM, Lentine KL: Delivery patterns of recommended chronic kidney disease care in clinical practice: administrative claims-based analysis and systematic literature review. Clin Exp Nephrol. 2008, 12 (1): 41-52. 10.1007/s10157-007-0016-3.CrossRefPubMed
12.
go back to reference Lea JP, McClellan WM, Melcher C, Gladstone E, Hostetter T: CKD risk factors reported by primary care physicians: do guidelines make a difference?. Am J Kidney Dis. 2006, 47 (1): 72-77. 10.1053/j.ajkd.2005.09.027.CrossRefPubMed Lea JP, McClellan WM, Melcher C, Gladstone E, Hostetter T: CKD risk factors reported by primary care physicians: do guidelines make a difference?. Am J Kidney Dis. 2006, 47 (1): 72-77. 10.1053/j.ajkd.2005.09.027.CrossRefPubMed
13.
go back to reference Lenz O, Fornoni A: Chronic kidney disease care delivered by US family medicine and internal medicine trainees: results from an online survey. BMC Med. 2006, 4: 30-10.1186/1741-7015-4-30.CrossRefPubMedPubMedCentral Lenz O, Fornoni A: Chronic kidney disease care delivered by US family medicine and internal medicine trainees: results from an online survey. BMC Med. 2006, 4: 30-10.1186/1741-7015-4-30.CrossRefPubMedPubMedCentral
14.
go back to reference National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002, 39 (2 Suppl 1): S1-S266. National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002, 39 (2 Suppl 1): S1-S266.
15.
go back to reference Greer RC, Powe NR, Jaar BG, Troll MU, Boulware LE: Effect of primary care physicians’ use of estimated glomerular filtration rate on the timing of their subspecialty referral decisions. BMC Nephrol. 2011, 12: 1-10.1186/1471-2369-12-1.CrossRefPubMedPubMedCentral Greer RC, Powe NR, Jaar BG, Troll MU, Boulware LE: Effect of primary care physicians’ use of estimated glomerular filtration rate on the timing of their subspecialty referral decisions. BMC Nephrol. 2011, 12: 1-10.1186/1471-2369-12-1.CrossRefPubMedPubMedCentral
16.
go back to reference Boulware LE, Troll MU, Jaar BG, Myers DI, Powe NR: Identification and referral of patients with progressive CKD: a national study. Am J Kidney Dis. 2006, 48 (2): 192-204. 10.1053/j.ajkd.2006.04.073.CrossRefPubMed Boulware LE, Troll MU, Jaar BG, Myers DI, Powe NR: Identification and referral of patients with progressive CKD: a national study. Am J Kidney Dis. 2006, 48 (2): 192-204. 10.1053/j.ajkd.2006.04.073.CrossRefPubMed
17.
go back to reference Agrawal V, Ghosh AK, Barnes MA, McCullough PA: Awareness and knowledge of clinical practice guidelines for CKD among internal medicine residents: a national online survey. Am J Kidney Dis. 2008, 52 (6): 1061-1069. 10.1053/j.ajkd.2008.06.022.CrossRefPubMed Agrawal V, Ghosh AK, Barnes MA, McCullough PA: Awareness and knowledge of clinical practice guidelines for CKD among internal medicine residents: a national online survey. Am J Kidney Dis. 2008, 52 (6): 1061-1069. 10.1053/j.ajkd.2008.06.022.CrossRefPubMed
18.
go back to reference Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group: KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013, 3: 1-150.CrossRef Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group: KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013, 3: 1-150.CrossRef
19.
go back to reference Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, Rubin HR: Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999, 282 (15): 1458-1465. 10.1001/jama.282.15.1458.CrossRefPubMed Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, Rubin HR: Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999, 282 (15): 1458-1465. 10.1001/jama.282.15.1458.CrossRefPubMed
20.
go back to reference U.S. Renal Data System: USRDS 2013 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United State. 2013, Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases U.S. Renal Data System: USRDS 2013 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United State. 2013, Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases
21.
go back to reference Agrawal V, Agarwal M, Ghosh AK, Barnes MA, McCullough PA: Identification and management of chronic kidney disease complications by internal medicine residents: a national survey. Am J Ther. 2011, 18 (3): e40-e47. 10.1097/MJT.0b013e3181bbf6fc.CrossRefPubMed Agrawal V, Agarwal M, Ghosh AK, Barnes MA, McCullough PA: Identification and management of chronic kidney disease complications by internal medicine residents: a national survey. Am J Ther. 2011, 18 (3): e40-e47. 10.1097/MJT.0b013e3181bbf6fc.CrossRefPubMed
22.
go back to reference Fox CH, Brooks A, Zayas LE, McClellan W, Murray B: Primary care physicians’ knowledge and practice patterns in the treatment of chronic kidney disease: an Upstate New York Practice-based Research Network (UNYNET) study. J Am Board Fam Med. 2006, 19 (1): 54-61. 10.3122/jabfm.19.1.54.CrossRefPubMed Fox CH, Brooks A, Zayas LE, McClellan W, Murray B: Primary care physicians’ knowledge and practice patterns in the treatment of chronic kidney disease: an Upstate New York Practice-based Research Network (UNYNET) study. J Am Board Fam Med. 2006, 19 (1): 54-61. 10.3122/jabfm.19.1.54.CrossRefPubMed
23.
24.
go back to reference Glassock RJ, Winearls CG: Routine reporting of estimated glomerular filtration rate: not ready for prime time. Nat Clin Pract Nephrol. 2008, 4 (8): 422-423.CrossRefPubMed Glassock RJ, Winearls CG: Routine reporting of estimated glomerular filtration rate: not ready for prime time. Nat Clin Pract Nephrol. 2008, 4 (8): 422-423.CrossRefPubMed
25.
go back to reference Patwardhan MB, Kawamoto K, Lobach D, Patel UD, Matchar DB: Recommendations for a clinical decision support for the management of individuals with chronic kidney disease. Clin J Am Soc Nephrol. 2009, 4 (2): 273-283. 10.2215/CJN.02590508.CrossRefPubMedPubMedCentral Patwardhan MB, Kawamoto K, Lobach D, Patel UD, Matchar DB: Recommendations for a clinical decision support for the management of individuals with chronic kidney disease. Clin J Am Soc Nephrol. 2009, 4 (2): 273-283. 10.2215/CJN.02590508.CrossRefPubMedPubMedCentral
26.
go back to reference Tuot DS, Plantinga LC, Hsu CY, Powe NR: Is awareness of chronic kidney disease associated with evidence-based guideline-concordant outcomes?. Am J Nephrol. 2012, 35 (2): 191-197. 10.1159/000335935.CrossRefPubMedPubMedCentral Tuot DS, Plantinga LC, Hsu CY, Powe NR: Is awareness of chronic kidney disease associated with evidence-based guideline-concordant outcomes?. Am J Nephrol. 2012, 35 (2): 191-197. 10.1159/000335935.CrossRefPubMedPubMedCentral
27.
go back to reference Greer RC, Crews DC, Boulware LE: Challenges perceived by primary care providers to educating patients about chronic kidney disease. J Ren Care. 2012, 38 (4): 174-181. 10.1111/j.1755-6686.2012.00323.x.CrossRefPubMedPubMedCentral Greer RC, Crews DC, Boulware LE: Challenges perceived by primary care providers to educating patients about chronic kidney disease. J Ren Care. 2012, 38 (4): 174-181. 10.1111/j.1755-6686.2012.00323.x.CrossRefPubMedPubMedCentral
28.
go back to reference Diamantidis CJ, Powe NR, Jaar BG, Greer RC, Troll MU, Boulware LE: Primary care-specialist collaboration in the care of patients with chronic kidney disease. Clin J Am Soc Nephrol. 2011, 6 (2): 334-343. 10.2215/CJN.06240710.CrossRefPubMedPubMedCentral Diamantidis CJ, Powe NR, Jaar BG, Greer RC, Troll MU, Boulware LE: Primary care-specialist collaboration in the care of patients with chronic kidney disease. Clin J Am Soc Nephrol. 2011, 6 (2): 334-343. 10.2215/CJN.06240710.CrossRefPubMedPubMedCentral
29.
go back to reference Plantinga LC, Boulware LE, Coresh J, Stevens LA, Miller ER, Saran R, Messer KL, Levey AS, Powe NR: Patient awareness of chronic kidney disease: trends and predictors. Arch Intern Med. 2008, 168 (20): 2268-2275. 10.1001/archinte.168.20.2268.CrossRefPubMedPubMedCentral Plantinga LC, Boulware LE, Coresh J, Stevens LA, Miller ER, Saran R, Messer KL, Levey AS, Powe NR: Patient awareness of chronic kidney disease: trends and predictors. Arch Intern Med. 2008, 168 (20): 2268-2275. 10.1001/archinte.168.20.2268.CrossRefPubMedPubMedCentral
30.
go back to reference Crinson I, Gallagher H, Thomas N, de Lusignan S: How ready is general practice to improve quality in chronic kidney disease? A diagnostic analysis. Br J Gen Pract. 2010, 60 (575): 403-409. 10.3399/bjgp10X502100.CrossRefPubMedPubMedCentral Crinson I, Gallagher H, Thomas N, de Lusignan S: How ready is general practice to improve quality in chronic kidney disease? A diagnostic analysis. Br J Gen Pract. 2010, 60 (575): 403-409. 10.3399/bjgp10X502100.CrossRefPubMedPubMedCentral
31.
go back to reference Nissenson AR, Collins AJ, Hurley J, Petersen H, Pereira BJ, Steinberg EP: Opportunities for improving the care of patients with chronic renal insufficiency: current practice patterns. J Am Soc Nephrol. 2001, 12 (8): 1713-1720.PubMed Nissenson AR, Collins AJ, Hurley J, Petersen H, Pereira BJ, Steinberg EP: Opportunities for improving the care of patients with chronic renal insufficiency: current practice patterns. J Am Soc Nephrol. 2001, 12 (8): 1713-1720.PubMed
32.
go back to reference Glassock RJ, Winearls C: An epidemic of chronic kidney disease: fact or fiction?. Nephrol Dial Transplant. 2008, 23 (4): 1117-1121.CrossRefPubMed Glassock RJ, Winearls C: An epidemic of chronic kidney disease: fact or fiction?. Nephrol Dial Transplant. 2008, 23 (4): 1117-1121.CrossRefPubMed
33.
go back to reference Glassock RJ, Winearls C: The global burden of chronic kidney disease: how valid are the estimates?. Nephron Clin Pract. 2008, 110 (1): c39-c46. 10.1159/000151244. discussion c47CrossRefPubMed Glassock RJ, Winearls C: The global burden of chronic kidney disease: how valid are the estimates?. Nephron Clin Pract. 2008, 110 (1): c39-c46. 10.1159/000151244. discussion c47CrossRefPubMed
34.
go back to reference Glassock RJ, Winearls C: Ageing and the glomerular filtration rate: truths and consequences. Trans Am Clin Climatol Assoc. 2009, 120: 419-428.PubMedPubMedCentral Glassock RJ, Winearls C: Ageing and the glomerular filtration rate: truths and consequences. Trans Am Clin Climatol Assoc. 2009, 120: 419-428.PubMedPubMedCentral
35.
go back to reference Winearls CG, Glassock RJ: Dissecting and refining the staging of chronic kidney disease. Kidney Int. 2009, 75 (10): 1009-1014. 10.1038/ki.2009.49.CrossRefPubMed Winearls CG, Glassock RJ: Dissecting and refining the staging of chronic kidney disease. Kidney Int. 2009, 75 (10): 1009-1014. 10.1038/ki.2009.49.CrossRefPubMed
36.
go back to reference Wetzels JF, Kiemeney LA, Swinkels DW, Willems HL, den Heijer M: Age- and gender-specific reference values of estimated GFR in Caucasians: the Nijmegen Biomedical Study. Kidney Int. 2007, 72 (5): 632-637. 10.1038/sj.ki.5002374.CrossRefPubMed Wetzels JF, Kiemeney LA, Swinkels DW, Willems HL, den Heijer M: Age- and gender-specific reference values of estimated GFR in Caucasians: the Nijmegen Biomedical Study. Kidney Int. 2007, 72 (5): 632-637. 10.1038/sj.ki.5002374.CrossRefPubMed
37.
go back to reference Edwards P, Roberts I, Clarke M, DiGuiseppi C, Wentz R, Kwan I, Cooper R, Felix L, Pratap S: Methods to increase response to postal and electronic questionnaires (Review). Cochrane Database Syst Rev. 2009, 3: 1-12. Edwards P, Roberts I, Clarke M, DiGuiseppi C, Wentz R, Kwan I, Cooper R, Felix L, Pratap S: Methods to increase response to postal and electronic questionnaires (Review). Cochrane Database Syst Rev. 2009, 3: 1-12.
38.
go back to reference Abdel-Kader K, Fischer GS, Johnston JR, Gu C, Moore CG, Unruh ML: Characterizing pre-dialysis care in the era of eGFR reporting: a cohort study. BMC Nephrol. 2011, 12: 12-10.1186/1471-2369-12-12.CrossRefPubMedPubMedCentral Abdel-Kader K, Fischer GS, Johnston JR, Gu C, Moore CG, Unruh ML: Characterizing pre-dialysis care in the era of eGFR reporting: a cohort study. BMC Nephrol. 2011, 12: 12-10.1186/1471-2369-12-12.CrossRefPubMedPubMedCentral
39.
go back to reference Hemmelgarn BR, Zhang J, Manns BJ, James MT, Quinn RR, Ravani P, Klarenbach SW, Culleton BF, Krause R, Thorlacius L, Jain AK, Tonelli M, Alberta Kidney Disease N: Nephrology visits and health care resource use before and after reporting estimated glomerular filtration rate. JAMA. 2010, 303 (12): 1151-1158. 10.1001/jama.2010.303.CrossRefPubMed Hemmelgarn BR, Zhang J, Manns BJ, James MT, Quinn RR, Ravani P, Klarenbach SW, Culleton BF, Krause R, Thorlacius L, Jain AK, Tonelli M, Alberta Kidney Disease N: Nephrology visits and health care resource use before and after reporting estimated glomerular filtration rate. JAMA. 2010, 303 (12): 1151-1158. 10.1001/jama.2010.303.CrossRefPubMed
40.
go back to reference Jain AK, Cuerden MS, McLeod I, Hemmelgarn B, Akbari A, Tonelli M, Quinn RR, Oliver MJ, Garg AX: Reporting of the estimated glomerular filtration rate was associated with increased use of angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers in CKD. Kidney Int. 2012, 81 (12): 1248-1253. 10.1038/ki.2012.18.CrossRefPubMed Jain AK, Cuerden MS, McLeod I, Hemmelgarn B, Akbari A, Tonelli M, Quinn RR, Oliver MJ, Garg AX: Reporting of the estimated glomerular filtration rate was associated with increased use of angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers in CKD. Kidney Int. 2012, 81 (12): 1248-1253. 10.1038/ki.2012.18.CrossRefPubMed
41.
go back to reference Kagoma YK, Weir MA, Iansavichus AV, Hemmelgarn BR, Akbari A, Patel UD, Garg AX, Jain AK: Impact of estimated GFR reporting on patients, clinicians, and health-care systems: a systematic review. Am J Kidney Dis. 2011, 57 (4): 592-601. 10.1053/j.ajkd.2010.08.029.CrossRefPubMed Kagoma YK, Weir MA, Iansavichus AV, Hemmelgarn BR, Akbari A, Patel UD, Garg AX, Jain AK: Impact of estimated GFR reporting on patients, clinicians, and health-care systems: a systematic review. Am J Kidney Dis. 2011, 57 (4): 592-601. 10.1053/j.ajkd.2010.08.029.CrossRefPubMed
42.
go back to reference Israni RK, Shea JA, Joffe MM, Feldman HI: Physician characteristics and knowledge of CKD management. Am J Kidney Dis. 2009, 54 (2): 238-247. 10.1053/j.ajkd.2009.01.258.CrossRefPubMed Israni RK, Shea JA, Joffe MM, Feldman HI: Physician characteristics and knowledge of CKD management. Am J Kidney Dis. 2009, 54 (2): 238-247. 10.1053/j.ajkd.2009.01.258.CrossRefPubMed
43.
go back to reference Jafar TH, Schmid CH, Landa M, Giatras I, Toto R, Remuzzi G, Maschio G, Brenner BM, Kamper A, Zucchelli P, Becker G, Himmelmann A, Bannister K, Landais P, Shahinfar S, de Jong PE, de Zeeuw D, Lau J, Levey AS: Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med. 2001, 135 (2): 73-87. 10.7326/0003-4819-135-2-200107170-00007.CrossRefPubMed Jafar TH, Schmid CH, Landa M, Giatras I, Toto R, Remuzzi G, Maschio G, Brenner BM, Kamper A, Zucchelli P, Becker G, Himmelmann A, Bannister K, Landais P, Shahinfar S, de Jong PE, de Zeeuw D, Lau J, Levey AS: Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med. 2001, 135 (2): 73-87. 10.7326/0003-4819-135-2-200107170-00007.CrossRefPubMed
44.
go back to reference Kent DM, Jafar TH, Hayward RA, Tighiouart H, Landa M, de Jong P, de Zeeuw D, Remuzzi G, Kamper AL, Levey AS: Progression risk, urinary protein excretion, and treatment effects of angiotensin-converting enzyme inhibitors in nondiabetic kidney disease. J Am Soc Nephrol. 2007, 18 (6): 1959-1965. 10.1681/ASN.2006101081.CrossRefPubMed Kent DM, Jafar TH, Hayward RA, Tighiouart H, Landa M, de Jong P, de Zeeuw D, Remuzzi G, Kamper AL, Levey AS: Progression risk, urinary protein excretion, and treatment effects of angiotensin-converting enzyme inhibitors in nondiabetic kidney disease. J Am Soc Nephrol. 2007, 18 (6): 1959-1965. 10.1681/ASN.2006101081.CrossRefPubMed
45.
go back to reference Sarnak MJ, Greene T, Wang X, Beck G, Kusek JW, Collins AJ, Levey AS: The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study. Ann Intern Med. 2005, 142 (5): 342-351. 10.7326/0003-4819-142-5-200503010-00009.CrossRefPubMed Sarnak MJ, Greene T, Wang X, Beck G, Kusek JW, Collins AJ, Levey AS: The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study. Ann Intern Med. 2005, 142 (5): 342-351. 10.7326/0003-4819-142-5-200503010-00009.CrossRefPubMed
46.
go back to reference Appel LJ, Wright JT, Greene T, Agodoa LY, Astor BC, Bakris GL, Cleveland WH, Charleston J, Contreras G, Faulkner ML, Gabbai FB, Gassman JJ, Hebert LA, Jamerson KA, Kopple JD, Kusek JW, Lash JP, Lea JP, Lewis JB, Lipkowitz MS, Massry SG, Miller ER, Norris K, Phillips RA, Pogue VA, Randall OS, Rostand SG, Smogorzewski MJ, Toto RD, Wang X: Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med. 2010, 363 (10): 918-929. 10.1056/NEJMoa0910975.CrossRefPubMedPubMedCentral Appel LJ, Wright JT, Greene T, Agodoa LY, Astor BC, Bakris GL, Cleveland WH, Charleston J, Contreras G, Faulkner ML, Gabbai FB, Gassman JJ, Hebert LA, Jamerson KA, Kopple JD, Kusek JW, Lash JP, Lea JP, Lewis JB, Lipkowitz MS, Massry SG, Miller ER, Norris K, Phillips RA, Pogue VA, Randall OS, Rostand SG, Smogorzewski MJ, Toto RD, Wang X: Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med. 2010, 363 (10): 918-929. 10.1056/NEJMoa0910975.CrossRefPubMedPubMedCentral
47.
go back to reference Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT, Chronic Kidney Disease Prognosis C: Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010, 375 (9731): 2073-2081.CrossRefPubMedPubMedCentral Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT, Chronic Kidney Disease Prognosis C: Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010, 375 (9731): 2073-2081.CrossRefPubMedPubMedCentral
48.
go back to reference Tonelli M, Muntner P, Lloyd A, Manns BJ, James MT, Klarenbach S, Quinn RR, Wiebe N, Hemmelgarn BR, Alberta Kidney Disease N: Using proteinuria and estimated glomerular filtration rate to classify risk in patients with chronic kidney disease: a cohort study. Ann Intern Med. 2011, 154 (1): 12-21. 10.7326/0003-4819-154-1-201101040-00003.CrossRefPubMed Tonelli M, Muntner P, Lloyd A, Manns BJ, James MT, Klarenbach S, Quinn RR, Wiebe N, Hemmelgarn BR, Alberta Kidney Disease N: Using proteinuria and estimated glomerular filtration rate to classify risk in patients with chronic kidney disease: a cohort study. Ann Intern Med. 2011, 154 (1): 12-21. 10.7326/0003-4819-154-1-201101040-00003.CrossRefPubMed
49.
go back to reference Tangri N, Stevens LA, Griffith J, Tighiouart H, Djurdjev O, Naimark D, Levin A, Levey AS: A predictive model for progression of chronic kidney disease to kidney failure. JAMA. 2011, 305 (15): 1553-1559. 10.1001/jama.2011.451.CrossRefPubMed Tangri N, Stevens LA, Griffith J, Tighiouart H, Djurdjev O, Naimark D, Levin A, Levey AS: A predictive model for progression of chronic kidney disease to kidney failure. JAMA. 2011, 305 (15): 1553-1559. 10.1001/jama.2011.451.CrossRefPubMed
50.
go back to reference Abdel-Kader K, Fischer GS, Li J, Moore CG, Hess R, Unruh ML: Automated clinical reminders for primary care providers in the care of CKD: a small cluster-randomized controlled trial. Am J Kidney Dis. 2011, 58 (6): 894-902. 10.1053/j.ajkd.2011.08.028.CrossRefPubMedPubMedCentral Abdel-Kader K, Fischer GS, Li J, Moore CG, Hess R, Unruh ML: Automated clinical reminders for primary care providers in the care of CKD: a small cluster-randomized controlled trial. Am J Kidney Dis. 2011, 58 (6): 894-902. 10.1053/j.ajkd.2011.08.028.CrossRefPubMedPubMedCentral
51.
go back to reference Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ, National Heart L, Blood Institute Joint National Committee on Prevention DE, Treatment of High Blood P, National High Blood Pressure Education Program Coordinating C: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. [see comment][erratum appears in JAMA. 2003 Jul 9;290(2):197. JAMA. 2003, 289 (19): 2560-2572. 10.1001/jama.289.19.2560.CrossRefPubMed Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ, National Heart L, Blood Institute Joint National Committee on Prevention DE, Treatment of High Blood P, National High Blood Pressure Education Program Coordinating C: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. [see comment][erratum appears in JAMA. 2003 Jul 9;290(2):197. JAMA. 2003, 289 (19): 2560-2572. 10.1001/jama.289.19.2560.CrossRefPubMed
52.
go back to reference O’Hare AM, Hotchkiss JR, Kurella Tamura M, Larson EB, Hemmelgarn BR, Batten A, Do TP, Covinsky KE: Interpreting treatment effects from clinical trials in the context of real-world risk information: end-stage renal disease prevention in older adults. JAMA Intern Med. 2014, 174 (3): 391-397. 10.1001/jamainternmed.2013.13328.CrossRefPubMedPubMedCentral O’Hare AM, Hotchkiss JR, Kurella Tamura M, Larson EB, Hemmelgarn BR, Batten A, Do TP, Covinsky KE: Interpreting treatment effects from clinical trials in the context of real-world risk information: end-stage renal disease prevention in older adults. JAMA Intern Med. 2014, 174 (3): 391-397. 10.1001/jamainternmed.2013.13328.CrossRefPubMedPubMedCentral
53.
go back to reference Lapi F, Azoulay L, Yin H, Nessim SJ, Suissa S: Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case–control study. BMJ. 2013, 346: e8525-10.1136/bmj.e8525.CrossRefPubMedPubMedCentral Lapi F, Azoulay L, Yin H, Nessim SJ, Suissa S: Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case–control study. BMJ. 2013, 346: e8525-10.1136/bmj.e8525.CrossRefPubMedPubMedCentral
54.
go back to reference Qaseem A, Hopkins RH, Sweet DE, Starkey M, Shekelle P, Clinical Guidelines Committee of the American College of P: Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2013, 159 (12): 835-847.PubMed Qaseem A, Hopkins RH, Sweet DE, Starkey M, Shekelle P, Clinical Guidelines Committee of the American College of P: Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2013, 159 (12): 835-847.PubMed
55.
go back to reference Fox CH, Vest BM, Kahn LS, Dickinson LM, Fang H, Pace W, Kimminau K, Vassalotti J, Loskutova N, Peterson K: Improving evidence-based primary care for chronic kidney disease: study protocol for a cluster randomized control trial for translating evidence into practice (TRANSLATE CKD). Implement Sci. 2013, 8: 88-10.1186/1748-5908-8-88.CrossRefPubMedPubMedCentral Fox CH, Vest BM, Kahn LS, Dickinson LM, Fang H, Pace W, Kimminau K, Vassalotti J, Loskutova N, Peterson K: Improving evidence-based primary care for chronic kidney disease: study protocol for a cluster randomized control trial for translating evidence into practice (TRANSLATE CKD). Implement Sci. 2013, 8: 88-10.1186/1748-5908-8-88.CrossRefPubMedPubMedCentral
56.
go back to reference Charles RF, Powe NR, Jaar BG, Troll MU, Parekh RS, Boulware LE: Clinical testing patterns and cost implications of variation in the evaluation of CKD among US physicians. Am J Kidney Dis. 2009, 54 (2): 227-237. 10.1053/j.ajkd.2008.12.044.CrossRefPubMedPubMedCentral Charles RF, Powe NR, Jaar BG, Troll MU, Parekh RS, Boulware LE: Clinical testing patterns and cost implications of variation in the evaluation of CKD among US physicians. Am J Kidney Dis. 2009, 54 (2): 227-237. 10.1053/j.ajkd.2008.12.044.CrossRefPubMedPubMedCentral
Metadata
Title
Primary care physicians’ familiarity, beliefs, and perceived barriers to practice guidelines in non-diabetic CKD: a survey study
Authors
Khaled Abdel-Kader
Raquel C Greer
L Ebony Boulware
Mark L Unruh
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2014
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-15-64

Other articles of this Issue 1/2014

BMC Nephrology 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.